The packed conference agenda now features a brand new presentation from Synaffix Founder and CSO, Floris van Delft. Highlights from the address entitled: Homogeneous and stable ADCs by GlycoConnectTM technology include:
· Site-specific, fully stable and homogeneous (DAR = 2.0)
· From any (off-the-shelf)
· Any IgG / any linker-toxin
· Optional: site-scanning
To see the new agenda visit www.adcsummit.com
Attendees at the 3rd annual conference will also have the opportunity to hear from industry leaders PolyTherics.
Director of Scientific Affairs - Bioconjugation & Protein Engineering, Dr George Badescu, will be providing unique insights on ThioBridge Conjugation with a focus on novel ADC formats, site specific conjugation, payloads, mAb and Fab conjugates.
A snap shot of confirmed attendees include:
Imperial College London
Merck Serono International
University of Oxford
ADC SUMMIT 2014
19TH – 20TH MAY 2014
Holiday Inn Kensington Forum, London UK
Sponsored by PolyTherics, Synaffix and Viventia Bio Inc
About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
More information can be found at www.smi-online.co.uk